Ad Header



The Pulse of the Pharmaceutical Industry

  • Filter By Category

  • Filter By Author

New chief medical officer for Neurocrine Biosciences

Christopher O’Brien, M.D., chief medical officer of Neurocrine Biosciences Inc., retired in February 2018 after a transition period with his successor.

Read More »

Agency Exec Shaun Urban Joins Inception Companies

Shaun Urban was named president of the Inception Companies.

Read More »

People on the Move: Specialty Pharma Companies

Wayne Swanton was promoted to executive VP, Global Operations, at Allergan Plc following notification that Rob Stewart, executive VP and chief operating officer, intended to leave Allergan to become president and CEO of Amneal Pharmaceuticals.

Read More »

People on the Move: Biotechnology Companies

Anu Balendran, Ph.D., was appointed VP Business Development at Alligator Bioscience.

Read More »

People on the Move: Service Companies

Michael Mulhern joined AMRI as CEO, succeeding William S. Marth.

Read More »

CVS launches care program to manage cost of RA

CVS Health introduced Transform Rheumatoid Arthritis Care to help the company’s pharmacy benefit management clients better manage care and costs for rheumatoid arthritis. The program is the latest addition to the company’s suite of condition-specific, highly personalized Transform Care programs and adds value-based management strategies including outcomes-based contracts and a new indication-based formulary for autoimmune conditions to CVS Health’s integrated pharmacy care model

Read More »

PBM signs on Jardiance for outcomes-based contract

As part of its CareCentered Contracting program, pharmacy benefit manager Prime Therapeutics LLC entered into an outcomes-based contract with Boehringer Ingelheim for Jardiance, an oral type 2 diabetes medicine indicated to reduce the risk of cardiovascular death in adults with type 2 diabetes and established cardiovascular disease.

Read More »

FDA Advisory Panel Spurns Pacira’s Request for Expanded Use of Pain Drug Exparel

Shares of Pacira Pharmaceuticals plunged more than 15 percent after the company revealed a U.S. Food and Drug Administration advisory panel recommended against approving expanded use of the company’s pain treatment Exparel.

Read More »

Superstar Investors Jump in on Celgene Spinout Celularity’s $250 Million Funding Round

With a high-profile group of investors and backers, Celgene Corp. spinout Celularity launched with $250 million.

Read More »

Swiss skiers first athletes hit by norovirus at Games

Two Swiss freestyle skiers were the first athletes confirmed to have been hit by a highly contagious virus that causes vomiting and diarrhea at the Pyeongchang Winter Games, the Swiss Olympic team confirmed on Friday.

Read More »

Ad Right Top


Extensive pharmaceutical business and marketing intelligence. For back issues, please contact

April 2019 Focus: Healthcare agency & network profiles, industry overview & awards, and more!


Ad Right Bottom